Diffusion-Weighted MR. Therapeutic Evaluation After Chemoembolization of VX-2 Carcinoma Implanted in Rabbit Liver

Academic Radiology

Volumn 15, Issue 5, 2008, Pages 593-600

  Youn, Byung Jae ^a   Chung, Jin Wook ^a   Son, Kyu Ri ^a   Kim, Hyo Cheol ^a   Jae, Hwan Jun ^a   Lee, Jeong Min ^a   Song, In Chan ^a   Kim, In One ^a   Park, Jae Hyung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

chemoembolization; Diffusion weighted MR; histology; liver tumor; rabbit

Indexed keywords

DOXORUBICIN; ETHYLBROMOPYRUVATE; GADOLINIUM PENTETATE; IODINATED POPPYSEED OIL; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CHEMOEMBOLIZATION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; LIVER CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; GADOLINIUM DTPA; LIVER NEOPLASMS; RABBITS;

EID: 42049103229     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.10.022     Document Type: Article

References (20)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Geschwind J.F. Chemoembolization for hepatocellular carcinoma: Where does the truth lie?. J Vasc Interv Radiol 13 (2002) 991-994
3. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37 (2003) 429-442
4. Bruix J., Sala M., and Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (2004) S179-S188
5. Kim H.C., Kim A.Y., Han J.K., et al. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: Added value of unenhanced images. Radiology 225 (2002) 773-780
6. Teefey S.A., Hildeboldt C.C., Dehdashti F., et al. Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET. Radiology 226 (2003) 533-542
7. Choi B.I. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl 10 (2004) S20-S25
8. Lu D.S., Yu N.C., Raman S.S., et al. Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver. Radiology 234 (2005) 954-960
9. Jang K.M., Choi D., Lim H.K., et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: Multiphasic helical CT with review of the previous serial CT images. Korean J Radiol 6 (2005) 153-160
10. Kuszyk B.S., Boitnott J.K., Choti M.A., et al. Local tumor recurrence following hepatic cryoablation: Radiologic-histopathologic correlation in a rabbit model. Radiology 217 (2000) 477-486
11. Ichikawa T., Haradome H., Hachiya J., et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: Detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170 (1998) 397-402
12. Chiu F.Y., Jao J.C., Chen C.Y., et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 29 (2005) 176-180
13. Kamel I.R., Bluemke D.A., Eng J., et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17 (2006) 505-512
14. Geschwind J.F., Artemov D., Abraham S., et al. Chemoembolization of liver tumor in a rabbit model: Assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 11 (2000) 1245-1255
15. Deng J., Rhee T.K., Sato K.T., et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 41 (2006) 410-414
16. Yuan Y.H., Xiao E.H., Xiang J., et al. MR diffusion-weighted imaging of rabbit liver VX-2 tumor. World J Gastroenterol 11 (2005) 3070-3074
17. Lang P., Wendland M.F., Saeed M., et al. Osteogenic sarcoma: Noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology 206 (1998) 227-235
18. Maier C.F., Paran Y., Bendel P., et al. Quantitative diffusion imaging in implanted human breast tumors. Magn Reson Med 37 (1997) 576-581
19. Thoeny H.C., De Keyzer F., Vandecaveye V., et al. Effect of vascular targeting agent in rat tumor model: Dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237 (2005) 492-499
20. Yoon C.J., Chung J.W., Park J.H., et al. Transcatheter arterial chemoembolization with paclitaxel-Lipiodol solution in rabbit VX2 liver tumor. Radiology 229 (2003) 126-131